Synaffix’s glycan-based antibody–drug conjugate technology is experiencing strong demand, based on its potential to improve safety and efficacy of cancer therapies without genetic engineering.
Abstract: This article introduces a hybrid Slepian beamforming receiver architecture with low power and area costs. Traditional large-scale true-time-delay (TTD) beamformers for wideband wireless ...
Check and improve your grammar with our basic grammar reference guide. On this page you'll find links to our basic grammar summary pages. Each basic grammar reference page covers a key grammar point ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results